title: Subacute cutaneous lupus erythematosus in a leuprorelin-treated patient with prostate carcinoma.
authors.forename: A
authors.initials: A
authors.lastname: Wiechert
authors.forename: T
authors.initials: T
authors.lastname: Tüting
authors.forename: T
authors.initials: T
authors.lastname: Bieber
authors.forename: G
authors.initials: G
authors.lastname: Haidl
authors.forename: J
authors.initials: J
authors.lastname: Wenzel
mesh_terms: D000287:Administration, Topical; D000368:Aged; D018931:Antineoplastic Agents, Hormonal / Q000009:adverse effects*; D006801:Humans; D016729:Leuprolide / Q000009:adverse effects*; D008178:Lupus Erythematosus, Cutaneous / Q000139:chemically induced* / Q000175:diagnosis / Q000188:drug therapy; D008297:Male; D011471:Prostatic Neoplasms / Q000188:drug therapy*; D013472:Sunlight / Q000009:adverse effects; D016896:Treatment Outcome
chemical_list: D018931:Antineoplastic Agents, Hormonal; D016729:Leuprolide